戻る Agenda
[V2-S5] Is the Risk Management Plan Really Effective? Part I
Session Chair(s)
Takuko Sawada
Director and Vice Chairperson of the Board
Shionogi & Co., Ltd., Japan
Junko Sato, PHD
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
From New Drug Reviewer's Point of View
Naoyuki Yabana, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Director, Office of In Vitro Diagnostics
From Japanese Company’s Point of View
Yomei Matsuoka, MSC, RPH
Daiichi Sankyo Co., Ltd., Japan
Vice President, Pharmacoepidemiology and PMS Department
From Foreign Company's Point of View
Lyo Inuyama, MD
Bayer Yakuhin, Ltd., Japan
Operating Officer, Head of Medical Affairs
RMP Review: From PMDA Safety Perspective
Noriyuki Komiyama, MSC
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office of Pharmacovigilance II